Irinotecan and cisplatin vs. cyclophosphamide, doxorubicin, and vincristine as second-line treatment after platinum and etoposide in small-cell lung cancer
Bilgi, O.; Karagoz, B.; Alacacioglu, A.; Ozgun, A.; Tuncel, T.; Gokhan-Kandemir, E.
Journal of BUON Official Journal of the Balkan Union of Oncology 15(2): 395
2010
ISSN/ISBN: 1107-0625 PMID: 20658743 Document Number: 644281
Document emailed within 1 workday
Related Documents
Unsal, M.; Erturk, D. 2003: Cisplatin and etoposide alternating ifosfamide, vincristine, epirubicin in small cell lung cancer Saudi Medical Journal 24(6): 628-631Joss, R.A.; Alberto, P.; Obrecht, J.P.; Barrelet, L.; Holdener, E.E.; Siegenthaler, P.; Goldhirsch, A.; Mermillod, B.; Cavalli, F. 1984: Combination chemotherapy for non-small cell lung cancer with doxorubicin and mitomycin or cisplatin and etoposide Cancer Treatment Reports 68(9): 1079-1084
Jones, A.L.; Holborn, J.; Ashley, S.; Smith, I.E. 1991: Effective new low toxicity chemotherapy with carboplatin, vinblastine and methotrexate for small cell lung cancer: a randomised trial against doxorubicin, cyclophosphamide and etoposide European Journal of Cancer 27(7): 866-870
Adachi, K.; Ogawa, M.; Inagaki, J.; Horikoshi, N.; Inoue, K.; Ikeda, K.; Usui, N.; Nakata, H.; Tada, A.; Aiba, K. 1984: A combination chemotherapy consisting of vincristine, etoposide and cyclophosphamide (VEC) for small cell carcinoma of the lung Gan to Kagaku Ryoho. Cancer and ChemoTherapy 11(8): 1617-1622
Zhang, X-Ru.; Zhu, Y-Zhong.; Xiu, Q-Yu.; Han, F-Cai.; Liu, D-Qi.; Chu, D-Tong. 2006: Irinotecan plus cisplatin for the treatment of advanced non-small cell lung cancer Zhonghua Zhong Liu Za Zhi 28(10): 777-779
Wachters, F.M.; Van Der Graaf, W.T.A.; Groen, H.J.M. 2004: Cardiotoxicity in advanced non-small cell lung cancer patients treated with platinum and non-platinum based combinations as first-line treatment Anticancer Research 24(3b): 2079-2083
Kosmidis, P.A.; Samantas, E.; Fountzilas, G.; Pavlidis, N.; Apostolopoulou, F.; Skarlos, D. 1994: Cisplatin/etoposide versus carboplatin/etoposide chemotherapy and irradiation in small cell lung cancer: a randomized phase IIi study. Hellenic Cooperative Oncology Group for Lung Cancer Trials Seminars in Oncology 21(3 Suppl 6: 23-30
Ardizzoni, A.; Canobbio, L.; Pronzato, P.; Repetto, L.; Serrano, J.; Benvenuto, F.; Simonassi, C.; Baracco, F.; Faravelli, B.; Nosenzo, M. 1986: Adriamycin, cyclophosphamide and etoposide (ACE) in the treatment of small cell lung cancer Chemioterapia: International Journal of the Mediterranean Society of ChemoTherapy 5(6): 416-419
Ryo, H.; Toyama, K.; Isobe, K.; Sugino, K.; Sano, G.; Yamada, H.; Hiroi, M.; Hojyo, T.; Kimura, K. 2003: A phase I study of gemcitabine and irinotecan as second line treatment for advanced non-small cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 30(2): 237-242
Lorigan, P.; Lee, S.M.; Betticher, D.; Woodhead, M.; Weir, D.; Hanley, S.; Hardy, C.; Thatcher, N. 1995: Chemotherapy with vincristine/ifosfamide/carboplatin/etoposide in small cell lung cancer Seminars in Oncology 22(3 Suppl 7: 32-41
Ishiura, Y.; Yamamoto, H.; Terasaki, Y.; Ishida, Y.; Tohge, M.; Segawa, M.; Kusajima, Y.; Saitoh, K.; Ishikawa, M.; Hirokami, N.; Kasahara, K.; Fujimura, M. 2011: Bevacizumab with platinum chemotherapy as 6th-line treatment in a case of non-small-cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 38(13): 2631-2633
Hino, M.; Kobayashi, K.; Yoshimura, A.; Takeda, Y.; Hisakatsu, S.; Yoneda, S.; Gemma, A.; Moriya, H.; Kudoh, S. 2006: Weekly administration of irinotecan (CPT-11) plus cisplatin for non-small cell lung cancer Anticancer Research 26(6c): 4697-4703
Natale, R.B. 2003: Irinotecan, cisplatin/carboplatin, and COX-2 inhibition in small-cell lung cancer Oncology 17(7 Suppl. 7): 22-26
Abad-Esteve, A.; Rosell, R.; Moreno, I.; Fernández-Marcial, C.; Roselló, M.; Ribas Mundó, M. 1988: VP-16, vincristine, adriamycin and cyclophosphamide (EVAC) in patients with small-cell lung cancer Medicina Clinica 90(14): 569-572
Perez, E.A.; Gandara, D.R. 1994: Etoposide/ifosfamide/cisplatin regimens in metastatic non-small cell lung cancer Seminars in Oncology 21(3 Suppl 4: 2-5
Chewaskulyong, B.; Thongprasert, S. 1998: Preliminary study of efficacy of intravenous cisplatin plus oral etoposide in small cell lung cancer Journal of the Medical Association of Thailand 81(1): 37-41
Splinter, T.; Kok, T.; Kho, S.; Lameris, H.; ten Kate, F.; Dalesio, O.; Dolman, B.; Palmen, F.; Bouvy, J.; Burghouts, J. 1986: A multicenter phase Ii trial of cisplatin and oral etoposide (VP-16) in inoperable non-small-cell lung cancer Seminars in Oncology 13(3 Suppl 3: 97-103
Charoentum, C.; Thongprasert, S.; Chewasakulyong, B.; Euathrongchit, J.; Sorraritchingchai, S.; Munprakan, S. 2007: Phase II study of cisplatin combined to irinotecan administered alternatingly with docetaxel in advanced non-small cell lung cancer Journal of the Medical Association of Thailand 90(11): 2506-2512
Tanaka, A.; Aragane, N.; Komiya, K.; Kawaura, F.; Fukuno, Y.; Hayashi, S. 2008: A pilot study of irinotecan hydrochloride(CPT-11)and cisplatin(CDDP)combination chemotherapy for previously treated non-small cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 35(1): 49-53
Shirinian, M.; Lee, J.S.; Dhingra, H.H.; Greenberg, J.; Hong, W.K. 1992: Phase II study of cisplatin, ifosfamide, and etoposide combination for advanced non-small cell lung cancer: final report Seminars in Oncology 19(6 Suppl. 12): 58-63